LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue.

Conclusion: LCK, via acting on T-cell receptor, might be a potential therapeutic target for AR after kidney transplantation.
PMID: 29977931 [PubMed - in process]

Source: Journal of Immunology Research - July 8, 2018 Category: Allergy & Immunology Tags: J Immunol Res Source Type: research